Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C14H21BrN2O2 |
Molar mass | 329.238 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
SSR180711 is a drug that acts as a potent and selective partial agonist for the α7 subtype of neural nicotinic acetylcholine receptors.[1][2] In animal studies, it shows nootropic effects and may be useful in the treatment of schizophrenia.[3][4]
AChE inhibitor medications | |
---|---|
Other medications | |
Experimental BACE inhibitors |